Biochem/physiol Actions
NR2B-selective, noncompetitive NMDA glutamate receptor antagonist
Features and Benefits
This compound is featured on the Glutamate Receptors (Ion Channel Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
- UPC:
- 10161823
- Condition:
- New
- HazmatClass:
- No
- MPN:
- R8900-5MG
akash.verma@cenmed.com
(732) 447-1115





